Skip to Main Content

Paper Details

Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer.
Ann Surg Oncol
3
2023
Anastrozole, BC, ER, ER+, Estrogen, Estrogen Receptor, Exemestane, Ki67, LRR, Letrozole, Patients, Women, aromatase, breast cancer, estrogen, estrogen receptor, estrogen receptor-positive (ER+) BC, patients, second, women
Author NameAffiliation
Kelly K HuntUT MD Anderson Cancer Center
Kelly K HuntUT MD Anderson Cancer Center
Vera J SumanMayo Clinic
Judy C BougheyMayo Clinic
Funda Meric-BernstamUT MD Anderson Cancer Center
Matthew J EllisBaylor College of Medicine
  • 1 - 6

Datasets

Release 1.2